SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) disclosed today that a report entitled, “The Aethlon Hemopurifier® - A Novel Treatment Strategy for Ebola & Marburg Haemorrhagic Fevers” is available to be accessed online at http://aethlonmedical.com/pdfs/cdcreportoct07.pdf. Ebola and Marburg are untreatable with antiviral drug and vaccine therapy, and are considered among the most deadly bioterror and pandemic threats known to mankind. The report discloses pre-clinical data that supports the potential use of the Hemopurifier® as treatment for Ebola and Marburg.
